Nuvation Bio Earnings
NYSE: NUVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.12
Nuvation Bio earnings summary
Nuvation Bio is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $-0.12. In its most recent report on Aug 6, 2026 (Q2 2026), NUVB posted EPS of $-0.18. Revenue for the quarter was $31.7 million.
Across the last 16 reports, NUVB shares moved an average of 6.3% (in either direction) in the first trading session after results, rising 6 times and falling 9 times.
Summary generated from market data by MetaCap's automated system. Methodology
NUVB earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.18 | — | -5.8% |
| May 4, 2026 | — | $0.01 | — | -9.8% |
| Mar 2, 2026 | — | $-0.11 | — | -3.3% |
| Nov 3, 2025 | — | $-0.16 | — | +2.7% |
| Aug 7, 2025 | — | $-0.17 | — | +19.6% |
| May 7, 2025 | — | $-0.16 | — | +8.1% |
| Mar 6, 2025 | — | $0.00 | — | +5.9% |
| Nov 6, 2024 | — | $-0.15 | — | -8.7% |
| Aug 5, 2024 | — | $-1.89 | — | -3.5% |
| May 14, 2024 | — | $-0.07 | — | -7.2% |
| Feb 29, 2024 | — | $-0.07 | — | +9.4% |
| Nov 2, 2023 | — | $-0.09 | — | -4.4% |
| Aug 3, 2023 | — | $-0.09 | — | +4.9% |
| May 4, 2023 | — | $-0.10 | — | -3.0% |
| Mar 15, 2023 | — | $-0.10 | — | 0.0% |
| Nov 3, 2022 | — | $-0.12 | — | -4.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.